A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

Clinical trial NCT07578571 · RECRUITING

Trial details

NCT number: NCT07578571
Sponsor: Immunome, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Non-Small Cell Lung Cancer Breast Cancer Esophageal Cancer Stomach Cancer Cancer

Start date: 2026-05-21
Primary completion: 2029-01-01
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.